Shares of Ocugen Inc. OCGN rallied 5.49% to $1.04 Tuesday, on what proved to be an all-around great trading session for the ...

Shares of Ocugen are trading lower Monday afternoon. The company earlier announced a definitive agreement to merge its subsidiary OrthoCellix with Carisma Therapeutics.

Shares of Ocugen Inc. OCGN slid 7.44% to $0.98 Monday, on what proved to be an all-around positive trading session for the ...

Biotech M&A is heating up, making small-cap firms with breakthrough assets top acquisition targets and potential big winners ...

After a tumultuous year of layoffs and strategic shifts, a Philadelphia biotech company has found a lifeline through a merger ...

Carisma Therapeutics (CARM) and OrthoCellix, a wholly-owned subsidiary of Ocugen (OCGN), announced that they have entered into a definitive merger agreement to combine the companies in an all-stock ...

Ocugen, a company in the healthcare sector, has experienced a notable decline in its stock price over the past week, dropping by 8.62%. Despite this downturn, analysts like Robert ...

Ocugen To Present at BIO International Convention 2025. MALVERN, Pa., June 11, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in ...

Investing.com -- Carisma Therapeutics Inc (NASDAQ: CARM) stock jumped 9.1% following the announcement of a definitive merger agreement with OrthoCellix, a wholly-owned subsidiary of Ocugen Inc (NASDAQ ...

The “bioindustrial revolution” is coming. Pennsylvania lawmakers want the commonwealth to be at its forefront.